
ICMR, Panacea Biotec initiate 1st dengue vaccine Phase 3 clinical trial exclusive
Introduction In a significant stride towards combating dengue fever, the Indian Council of Medical Research (ICMR) and Panacea Biotec have embarked on the first Phase 3 clinical trial for a dengue vaccine. This development marks a crucial milestone in the ongoing battle against dengue, a mosquito-borne viral infection that poses a significant public health challenge…